Director/PDMR Shareholding
13 November 2026
Carclo plc
Director/PDMR Shareholding
Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities (“PDMRs”) and persons closely associated with them
Carclo plc (the "Company"), a global precision engineering group with comprehensive, end-to-end manufacturing capabilities, announces that conditional awards over Carclo plc ordinary shares of 5 pence each ("Ordinary Shares") granted on 21 September 2023 under the Carclo plc Performance Share Plan 2017 (the "Plan") to certain PDMRs have vested.
The awards were subject to performance conditions measured over a three-year performance period ending on 21 September 2026. The Remuneration Committee has determined that the performance conditions were satisfied to the extent of 22.6% and, accordingly, the awards have vested as to 22.6% of the Ordinary Shares under award with the balance lapsing. The vesting date of the awards is 21 September 2026.
The vested awards have been satisfied by the allotment and issue of new Ordinary Shares to the trustee of the Company's employee benefit trust, of which certain shares have been transferred to Gary Allan and Alan Hook to be held in certificated form in their own names. The Ordinary Shares vesting to Frank Doorenbosch, as an executive director, are subject to a further two-year post-vesting holding period ending on 21 September 2028.
Details of the vesting for each PDMR are set out below:
Name
Position
No. of shares under award
Vesting %
No. of shares vested
Frank Doorenbosch
Chief Executive Officer
1,250,000
22.6%
282,500
Gary Allan
Chief Operating Officer
200,000
22.6%
45,200
Alan Hook
CEO – Aerospace Division
200,000
22.6%
45,200
On 10 November 2026, the trustee of the Company's employee benefit trust sold a total of 170,991 Ordinary Shares at a price of 38.25 pence per Ordinary Share to satisfy the income tax and National Insurance contributions arising on vesting for participants in the Plan, of which 143,618 Ordinary Shares were sold in respect of the PDMRs, as set out below. Following the sale, on 12 November 2026, the trustee transferred the remaining vested Ordinary Shares to the PDMRs, as set out below.
An application was made for 487,030 new Ordinary Shares, issued in connection with the vesting of awards under the Plan, and admission took place on 21 October 2026. The new Ordinary Shares rank pari passu with the existing Ordinary Shares. Consequently, the Company's issued share capital consists of 73,906,223 Ordinary Shares, each with one vote. The Company holds no Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 73,906,223. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
This announcement and the following disclosures are made in accordance with Article 19 of the UK Market Abuse Regulation.
1
Details of the person discharging managerial responsibilities / person closely associated
(a)
Name
(i) Frank Doorenbosch
(ii) Gary Allan
(iii) Alan Hook
2
Reason for the notification
(a)
Position/status
(i) Chief Executive Officer
(ii) Chief Operating Officer
(iii) CEO (Aerospace Division)
(b)
Initial notification / Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Carclo plc
(b)
LEI
21380078MEM399JPI956
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument
Ordinary Shares of 5 pence each
Identification code
ISIN: GB0001751915
(b)
Nature of the transaction
Acquisition of Ordinary Shares on transfer by the trustee of the Company's employee benefit trust following the vesting of conditional awards granted on 21 September 2023 under the Carclo plc Performance Share Plan 2017, net of Ordinary Shares sold to satisfy income tax and National Insurance contributions.
(c)
Price(s) and volume(s)
See table below
Name
Price
Volume (Ordinary Shares transferred)
Frank Doorenbosch
Nil
161,262
Gary Allan
Nil
44,337
Alan Hook
Nil
23,683
4 (cont.)
(d)
Aggregated information: Aggregated volume; Price
Not applicable – see individual details above
(e)
Date of the transaction
12 November 2026
(f)
Place of the transaction
Outside a trading venue
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument, type of instrument
Ordinary Shares of 5 pence each
Identification code
ISIN: GB0001751915
(b)
Nature of the transaction
Sale of Ordinary Shares to satisfy income tax and National Insurance contributions arising on the vesting of awards under the Plan
(c)
Price(s) and volume(s)
See table below
Name
Price
Volume
Frank Doorenbosch
38.25p
121,238
Gary Allan
38.25p
863
Alan Hook
38.25p
21,517
4 (cont.)
(d)
Aggregated information: Aggregated volume; Price
Not applicable – see individual details above
(e)
Date of the transaction
10 November 2026
(f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
About Carclo plc:
Carclo is a global precision engineering group that designs, industrialises and manufactures highly reliable solutions for Life Sciences, Aerospace and Safety & Security markets, manufactured in-region, for-region.
Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. LEI: 21380078MEM399JPI956
Enquiries:
Carclo plc +44 (0) 20 8685 0500
Frank Doorenbosch Chief Executive Officer
Ian Tichias Chief Financial Officer
Pheobe Greenwood Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBLBDBUUBDGLX
